Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia

被引：24
|
作者：
Gomez-Almaguer, David [1 ,2 ]
Colunga-Pedraza, Perla R. [1 ,2 ]
Gomez-De Leon, Andres [1 ,2 ]
Gutierrez-Aguirre, Cesar H. [1 ,2 ]
Cantu-Rodriguez, Olga G. [1 ,2 ]
Jaime-Perez, Jose C. [1 ,2 ]
机构：
[1] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Nuevo Leon, Mexico
[2] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Haematol Serv, Monterrey, Nuevo Leon, Mexico
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 184卷 / 02期
关键词：
immune thrombocytopenia; eltrombopag; rituximab; dexamethasone; THERAPY;
D O I：
10.1111/bjh.15070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 290
页数：3
相关论文
共 50 条
  • [1] Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
    Gomez-Almaguer, David
    Herrera-Rojas, Miguel A.
    Jaime-Perez, Jose C.
    Gomez-De Leon, Andres
    Cantu-Rodriguez, Olga G.
    Gutierrez-Aguirre, Cesar H.
    Tarin-Arzaga, Luz
    Hernandez-Reyes, Jesus
    Ruiz-Arguelles, Guillermo J.
    BLOOD, 2014, 123 (25) : 3906 - 3908
  • [2] Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study
    Colunga-Pedraza, Perla R.
    De la Garza-Salazar, Fernando
    Vaquera-Alfaro, Hector A.
    Gomez-De Leon, Andres
    Bustillos-Munoz, Monica
    Tarin-Arzaga, Luz
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [3] Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia
    Coronado-Alejandro, Edgar Ulises
    Martinez-Hernandez, Juan Pablo
    Gomez-De Leon, Andres
    Colunga-Pedraza, Perla Rocio
    Jaime-Perez, Jose Carlos
    Cantu-Rodriguez, Olga Graciela
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (06) : 778 - 779
  • [4] Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia
    Hu Zhou
    Liu Liu
    Xinhui Shu
    Xiaoran Wang
    Yongping Song
    Indian Journal of Hematology and Blood Transfusion, 2019, 35 : 507 - 512
  • [5] Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia
    Zhou, Hu
    Liu, Liu
    Shu, Xinhui
    Wang, Xiaoran
    Song, Yongping
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2019, 35 (03) : 507 - 512
  • [6] High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz
    Moreno-Jaime, Brizio
    Carlos Jaime-Perez, Jose
    Alejandro Ceballos-Lopez, Adrian
    Ruiz-Argueelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Graciela Cantu-Rodriguez, Olga
    Homero Gutierrez-Aguirre, Cesar
    Sanchez-Cardenas, Monica
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (06) : 494 - 500
  • [7] Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
    Yao, Mingkang
    Zhang, Jingjing
    Li, Ying
    Lv, Linlin
    Jia, Lu
    Yang, Chunyan
    Huang, Yu
    Liu, Haihui
    Wang, Jian
    Chen, Mingtai
    Zhang, Hao
    MEDICINE, 2022, 101 (04) : E28679
  • [8] Is There a Role for Low-Dose Eltrombopag as Maintenance Therapy in the Treatment of Immune Thrombocytopenia?
    Vlachaki, Efthymia
    Sousos, Nikolaos
    Perifanis, Vasilios
    Kaiafa, Georgia
    Onoufriadis, Ilias
    Hatzitolios, Apostolos
    Boura, Panagiota
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 78 - 82
  • [9] Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia
    Musto, P.
    Simeon, V.
    Martorelli, M. C.
    Petrucci, M. T.
    Cascavilla, N.
    Di Raimondo, F.
    Caravita, T.
    Morabito, F.
    Offidani, M.
    Olivieri, A.
    Benevolo, G.
    Mina, R.
    Guariglia, R.
    D'Arena, G.
    Mansueto, G.
    Filardi, N.
    Nobile, F.
    Levi, A.
    Falcone, A.
    Cavalli, M.
    Pietrantuono, G.
    Villani, O.
    Bringhen, S.
    Omede, P.
    Lerose, R.
    Agnelli, L.
    Todoerti, K.
    Neri, A.
    Boccadoro, M.
    Palumbo, A.
    LEUKEMIA, 2014, 28 (01) : 222 - 225
  • [10] Low-dose rituximab in adult patients with primary immune thrombocytopenia
    Zaja, Francesco
    Vianelli, Nicola
    Volpetti, Stefano
    Battista, Marta Lisa
    Defina, Marzia
    Palmieri, Salvatore
    Bocchia, Monica
    Medeot, Marta
    De Luca, Stefano
    Ferrara, Felicetto
    Isola, Miriam
    Baccarani, Michele
    Fanin, Renato
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (04) : 329 - 334
12345